Cargando…
Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease
Diabetes reduces the number and induces dysfunction in circulating endothelial progenitor cells (EPCs) by mechanisms that are still uncovered. This study aims to evaluate the number, viability, phenotype, and function of EPCs in dyslipidemic mice with early diabetes mellitus and EPC infiltration in...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563030/ https://www.ncbi.nlm.nih.gov/pubmed/32841051 http://dx.doi.org/10.1177/0963689720946277 |
_version_ | 1783595399651524608 |
---|---|
author | Filippi, Alexandru Constantin, Alina Alexandru, Nicoleta Voicu, Geanina Constantinescu, Cristina Ana Rebleanu, Daniela Fenyo, Madalina Simionescu, Dan Simionescu, Agneta Manduteanu, Ileana Georgescu, Adriana |
author_facet | Filippi, Alexandru Constantin, Alina Alexandru, Nicoleta Voicu, Geanina Constantinescu, Cristina Ana Rebleanu, Daniela Fenyo, Madalina Simionescu, Dan Simionescu, Agneta Manduteanu, Ileana Georgescu, Adriana |
author_sort | Filippi, Alexandru |
collection | PubMed |
description | Diabetes reduces the number and induces dysfunction in circulating endothelial progenitor cells (EPCs) by mechanisms that are still uncovered. This study aims to evaluate the number, viability, phenotype, and function of EPCs in dyslipidemic mice with early diabetes mellitus and EPC infiltration in the aortic valve in order to identify possible therapeutic targets in diabetes-associated cardiovascular disease. A streptozotocin-induced diabetic apolipoprotein E knock-out (ApoE(−/−)) mouse model was used to identify the early and progressive changes, at 4 or 7 days on atherogenic diet after the last streptozotocin or citrate buffer injection. Blood and aortic valves from diabetic or nondiabetic ApoE(−/−) animals were collected. EPCs were identified as CD34 and vascular endothelial growth factor receptor 2 positive monocytes, and the expression levels of α(4)β(1), α(V)β(3), α(V)β(5), β(1), α(L)β(2), α(5) integrins, and C-X-C chemokine receptor type 4 chemokine receptor on EPC surface were assessed by flow cytometry. The number of CD34 positive cells in the aortic valve, previously found to be recruited progenitor cells, was measured by fluorescence microscopy. Our results show that aortic valves from mice fed 7 days with atherogenic diet presented a significantly higher number of CD34 positive cells compared with mice fed only 4 days with the same diet, and diabetes reversed this finding. We also show a reduction of circulatory EPC numbers in diabetic mice caused by cell senescence and lower mobilization. Dyslipidemia induced EPC death through apoptosis regardless of the presence of diabetes, as shown by the higher percent of propidium iodide positive cells and higher cleaved caspase-3 levels. EPCs from diabetic mice expressed α4β1 and α(V)β(3) integrins at a lower level, while the rest of the integrins tested were unaffected by diabetes or diet. In conclusion, reduced EPC number and expression of α4β1 and αVβ3 integrins on EPCs at 4 and 7 days after diabetes induction in atherosclerosis-prone mice have resulted in lower recruitment of EPCs in the aortic valve. |
format | Online Article Text |
id | pubmed-7563030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-75630302020-10-26 Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease Filippi, Alexandru Constantin, Alina Alexandru, Nicoleta Voicu, Geanina Constantinescu, Cristina Ana Rebleanu, Daniela Fenyo, Madalina Simionescu, Dan Simionescu, Agneta Manduteanu, Ileana Georgescu, Adriana Cell Transplant Original Article Diabetes reduces the number and induces dysfunction in circulating endothelial progenitor cells (EPCs) by mechanisms that are still uncovered. This study aims to evaluate the number, viability, phenotype, and function of EPCs in dyslipidemic mice with early diabetes mellitus and EPC infiltration in the aortic valve in order to identify possible therapeutic targets in diabetes-associated cardiovascular disease. A streptozotocin-induced diabetic apolipoprotein E knock-out (ApoE(−/−)) mouse model was used to identify the early and progressive changes, at 4 or 7 days on atherogenic diet after the last streptozotocin or citrate buffer injection. Blood and aortic valves from diabetic or nondiabetic ApoE(−/−) animals were collected. EPCs were identified as CD34 and vascular endothelial growth factor receptor 2 positive monocytes, and the expression levels of α(4)β(1), α(V)β(3), α(V)β(5), β(1), α(L)β(2), α(5) integrins, and C-X-C chemokine receptor type 4 chemokine receptor on EPC surface were assessed by flow cytometry. The number of CD34 positive cells in the aortic valve, previously found to be recruited progenitor cells, was measured by fluorescence microscopy. Our results show that aortic valves from mice fed 7 days with atherogenic diet presented a significantly higher number of CD34 positive cells compared with mice fed only 4 days with the same diet, and diabetes reversed this finding. We also show a reduction of circulatory EPC numbers in diabetic mice caused by cell senescence and lower mobilization. Dyslipidemia induced EPC death through apoptosis regardless of the presence of diabetes, as shown by the higher percent of propidium iodide positive cells and higher cleaved caspase-3 levels. EPCs from diabetic mice expressed α4β1 and α(V)β(3) integrins at a lower level, while the rest of the integrins tested were unaffected by diabetes or diet. In conclusion, reduced EPC number and expression of α4β1 and αVβ3 integrins on EPCs at 4 and 7 days after diabetes induction in atherosclerosis-prone mice have resulted in lower recruitment of EPCs in the aortic valve. SAGE Publications 2020-08-25 /pmc/articles/PMC7563030/ /pubmed/32841051 http://dx.doi.org/10.1177/0963689720946277 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Filippi, Alexandru Constantin, Alina Alexandru, Nicoleta Voicu, Geanina Constantinescu, Cristina Ana Rebleanu, Daniela Fenyo, Madalina Simionescu, Dan Simionescu, Agneta Manduteanu, Ileana Georgescu, Adriana Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in Aortic Valve Disease |
title | Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells
from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in
Aortic Valve Disease |
title_full | Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells
from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in
Aortic Valve Disease |
title_fullStr | Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells
from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in
Aortic Valve Disease |
title_full_unstemmed | Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells
from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in
Aortic Valve Disease |
title_short | Integrins α4β1 and αVβ3 are Reduced in Endothelial Progenitor Cells
from Diabetic Dyslipidemic Mice and May Represent New Targets for Therapy in
Aortic Valve Disease |
title_sort | integrins α4β1 and αvβ3 are reduced in endothelial progenitor cells
from diabetic dyslipidemic mice and may represent new targets for therapy in
aortic valve disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563030/ https://www.ncbi.nlm.nih.gov/pubmed/32841051 http://dx.doi.org/10.1177/0963689720946277 |
work_keys_str_mv | AT filippialexandru integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT constantinalina integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT alexandrunicoleta integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT voicugeanina integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT constantinescucristinaana integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT rebleanudaniela integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT fenyomadalina integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT simionescudan integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT simionescuagneta integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT manduteanuileana integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease AT georgescuadriana integrinsa4b1andavb3arereducedinendothelialprogenitorcellsfromdiabeticdyslipidemicmiceandmayrepresentnewtargetsfortherapyinaorticvalvedisease |